Company
Lux Capital
Venture capital firm focused on science and technology companies at the frontier of what is possible
Venture Capital
News
Interviews (4)
Josh Wolfe on Lux Capital's $1.5B fund, the bifurcation of venture, and defense tech IPOs coming in 2026
8 Jan 2026
Lux Capital's Deena Shakir on AI in healthcare: scribes are crowded, clinical trials and drug development are the real opportunity
23 Jul 2025
Josh Wolfe on Reflect Orbital, Basic Capital, the collapse of science funding, and his skepticism of humanoid robots
15 May 2025
Josh Wolfe on defense tech bubble risks, sail drone's pivot to gray, and why maintenance is the unsexy investment theme of the decade
1 May 2025